Adherium Limited

OTCPK:ADRM.D Stock Report

Market Cap: US$4.4m

Adherium Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:ADRM.D Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Jun 26BuyUS$221,512Trudell Medical LimitedCompany1,053,315.36US$0.21
22 Jun 26BuyUS$20,329Louis PanaccioIndividual96,666.64US$0.21
19 Mar 26BuyUS$522Bruce McHarrieIndividual2,468.8US$0.21
24 Feb 26BuyUS$32,507Louis PanaccioIndividual153,333.36US$0.21
24 Feb 26BuyUS$1,190,030Trudell Medical LimitedCompany5,613,351.3US$0.21
23 Feb 26SellUS$11,485UBS Asset Management AGCompany38,422.66US$0.30
20 Feb 26BuyUS$11,539UBS Asset Management AGCompany35,320.48US$0.33
15 Jan 26SellUS$68,425Regal Partners LimitedCompany170,000US$0.40
29 Dec 25BuyUS$2,392UBS Asset Management AGCompany7,150.77US$0.33
05 Dec 25BuyUS$13,264Keven GessnerIndividual40,000US$0.33
13 Nov 25SellUS$577UBS Asset Management AGCompany2,200US$0.26
11 Nov 25BuyUS$384,162Regal Partners LimitedCompany1,176,965.52US$0.33
11 Nov 25SellUS$653UBS Asset Management AGCompany2,000US$0.33
29 Oct 25BuyUS$27,443UBS Asset Management AGCompany86,517.24US$0.32
11 Oct 25BuyUS$325,100Bioscience Managers Pty LtdCompany1,000,000US$0.33
02 Oct 25SellUS$1,514UBS Asset Management AGCompany4,600US$0.33
04 Aug 25BuyUS$181,721Bioscience Managers Pty LtdCompany562,080.82US$0.32

Insider Trading Volume

Insider Buying: ADRM.D insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ADRM.D?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,668,5393.04%
Hedge Funds4,653,4808.48%
Institutions6,496,21311.8%
VC/PE Firms7,434,54713.5%
Private Companies15,410,40428.1%
General Public19,224,10435%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 205.4%.

Top Shareholders

Top 25 shareholders own 64.98% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.9%
Trudell Medical Limited
15,310,404US$1.2m7.39%no data
13.6%
Bioscience Managers Pty Ltd
7,434,547US$598.4k17.9%63.03%
8.48%
Regal Partners Limited
4,653,480US$374.6k-3.52%0.02%
5.03%
UBS Asset Management AG
2,763,495US$222.4k-0.11%no data
2.68%
K1W1
1,468,362US$118.2k37.4%2.53%
1.47%
Bank of America Corporation
807,433US$65.0k0%no data
1.42%
Fidelity International Ltd
779,821US$62.8k0%no data
0.87%
Louis Panaccio
480,001US$38.6k25.2%no data
0.7%
Eduard Eshuys
386,000US$31.1k0%no data
0.47%
Merrill Lynch, Pierce, Fenner & Smith Incorporated
258,925US$20.8k0%no data
0.47%
JPMorgan Chase & Co.
258,177US$20.8k0%no data
0.29%
Scintilla Capital Pty Ltd
160,000US$12.9k0%0.29%
0.23%
Richard Hopkins
125,600US$10.1k0%no data
0.21%
Andrew Jackson
117,720US$9.5k0%no data
0.21%
Paul Mastoridis
116,000US$9.3k0%no data
0.2%
James Christmas Hansen
111,000US$8.9k0%no data
0.18%
Auraria Group Pty Ltd
100,000US$8.0k0%no data
0.17%
Carlsen Wilson Marks
95,000US$7.6k0%no data
0.17%
Edwina Marks
95,000US$7.6k0%no data
0.14%
George Baran
75,000US$6.0k0%no data
0.073%
Keven Gessner
40,000US$3.2k0%no data
0.032%
Bryan Mogridge
17,508US$1.4k0%no data
0.011%
Bruce McHarrie
6,172US$496.60%no data
0.0033%
Jeremy Curnock-Cook
1,796US$144.50.06%no data
0.0032%
William Hunter
1,742US$140.10%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/23 21:39
End of Day Share Price 2026/06/23 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Adherium Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterBell Potter
Dennis HulmeEdison Investment Research
Chris KallosMST Financial Services Pty Limited